Physician profile
Mark D Jessen
NPI 1033174982
$224.54
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.29 · 2020: $16.78 · 2021: $22.87 · 2022: $94.35 · 2023: $18.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $72.29 | 2019 | |
| Baudax Bio INC. | $22.87 | 2021 | |
| Merck Sharp & Dohme LLC | $22.58 | 2022 | |
| Endomagnetics Ltd | $22.52 | 2022 | |
| Stryker Corporation | $22.20 | 2022 | |
| Molli Surgical (US) INC | $18.25 | 2023 | |
| Tela Bio, INC. | $16.78 | 2020 | |
| Ambu INC. | $13.72 | 2022 | |
| Leica Microsystems INC. | $13.33 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Jessen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.